vs
Immunovant, Inc.（IMVT）与Taysha Gene Therapies, Inc.（TSHA）财务数据对比。点击上方公司名可切换其他公司
Immunovant, Inc.的季度营收约是Taysha Gene Therapies, Inc.的1.5倍（$8.4M vs $5.5M），Taysha Gene Therapies, Inc.净利率更高（-507.8% vs -899.0%，领先391.2%），Taysha Gene Therapies, Inc.同比增速更快（171.3% vs 140.7%）
Immunovant是一家临床阶段生物制药企业，专注于开发用于治疗严重、罕见自身免疫性疾病及炎症性疾病的新型单克隆抗体疗法，其核心在研候选产品覆盖多种自身免疫适应症，面向全球医疗市场布局研发管线。
Taysha基因疗法公司是一家处于临床阶段的生物技术企业，专注开发基于腺相关病毒（AAV）的基因疗法，用于治疗存在大量未满足医疗需求的罕见单基因型中枢神经系统疾病，管线覆盖多种致命性神经病症，核心市场面向北美及欧洲地区。
IMVT vs TSHA — 直观对比
营收规模更大
IMVT
是对方的1.5倍
$5.5M
营收增速更快
TSHA
高出30.5%
140.7%
净利率更高
TSHA
高出391.2%
-899.0%
损益表 — Q4 FY2024 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $8.4M | $5.5M |
| 净利润 | $-75.3M | $-27.9M |
| 毛利率 | — | — |
| 营业利润率 | -896.2% | -516.0% |
| 净利率 | -899.0% | -507.8% |
| 营收同比 | 140.7% | 171.3% |
| 净利润同比 | -26.7% | -48.3% |
| 每股收益（稀释后） | $-0.50 | $-0.08 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IMVTTSHA
| Q4 25 | — | $5.5M | ||
| Q3 25 | — | $0 | ||
| Q2 25 | — | $2.0M | ||
| Q1 25 | — | $2.3M | ||
| Q4 24 | — | $2.0M | ||
| Q3 24 | — | $1.8M | ||
| Q2 24 | — | $1.1M | ||
| Q1 24 | $8.4M | $3.4M |
净利润IMVTTSHA
| Q4 25 | — | $-27.9M | ||
| Q3 25 | — | $-32.7M | ||
| Q2 25 | — | $-26.9M | ||
| Q1 25 | — | $-21.5M | ||
| Q4 24 | — | $-18.8M | ||
| Q3 24 | — | $-25.5M | ||
| Q2 24 | — | $-20.9M | ||
| Q1 24 | $-75.3M | $-24.1M |
营业利润率IMVTTSHA
| Q4 25 | — | -516.0% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -1347.1% | ||
| Q1 25 | — | -930.5% | ||
| Q4 24 | — | -985.8% | ||
| Q3 24 | — | -1448.4% | ||
| Q2 24 | — | -1915.4% | ||
| Q1 24 | -896.2% | -713.3% |
净利率IMVTTSHA
| Q4 25 | — | -507.8% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -1353.6% | ||
| Q1 25 | — | -935.2% | ||
| Q4 24 | — | -929.0% | ||
| Q3 24 | — | -1427.5% | ||
| Q2 24 | — | -1882.0% | ||
| Q1 24 | -899.0% | -705.4% |
每股收益（稀释后）IMVTTSHA
| Q4 25 | — | $-0.08 | ||
| Q3 25 | — | $-0.09 | ||
| Q2 25 | — | $-0.09 | ||
| Q1 25 | — | $-0.08 | ||
| Q4 24 | — | $-0.07 | ||
| Q3 24 | — | $-0.10 | ||
| Q2 24 | — | $-0.09 | ||
| Q1 24 | $-0.50 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $635.4M | $319.8M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $617.8M | $246.9M |
| 总资产 | $666.4M | $343.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资IMVTTSHA
| Q4 25 | — | $319.8M | ||
| Q3 25 | — | $297.3M | ||
| Q2 25 | — | $312.8M | ||
| Q1 25 | — | $116.6M | ||
| Q4 24 | — | $139.0M | ||
| Q3 24 | — | $157.7M | ||
| Q2 24 | — | $172.7M | ||
| Q1 24 | $635.4M | $124.0M |
股东权益IMVTTSHA
| Q4 25 | — | $246.9M | ||
| Q3 25 | — | $219.0M | ||
| Q2 25 | — | $248.7M | ||
| Q1 25 | — | $55.1M | ||
| Q4 24 | — | $71.5M | ||
| Q3 24 | — | $88.8M | ||
| Q2 24 | — | $108.9M | ||
| Q1 24 | $617.8M | $53.8M |
总资产IMVTTSHA
| Q4 25 | — | $343.3M | ||
| Q3 25 | — | $316.6M | ||
| Q2 25 | — | $333.3M | ||
| Q1 25 | — | $138.4M | ||
| Q4 24 | — | $160.4M | ||
| Q3 24 | — | $180.2M | ||
| Q2 24 | — | $200.4M | ||
| Q1 24 | $666.4M | $153.0M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-59.7M | $-26.7M |
| 自由现金流经营现金流 - 资本支出 | $-59.8M | — |
| 自由现金流率自由现金流/营收 | -714.4% | — |
| 资本支出强度资本支出/营收 | 1.8% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-214.6M | — |
8季度趋势，按日历期对齐
经营现金流IMVTTSHA
| Q4 25 | — | $-26.7M | ||
| Q3 25 | — | $-24.2M | ||
| Q2 25 | — | $-20.2M | ||
| Q1 25 | — | $-22.0M | ||
| Q4 24 | — | $-18.3M | ||
| Q3 24 | — | $-21.6M | ||
| Q2 24 | — | $-21.5M | ||
| Q1 24 | $-59.7M | $-19.8M |
自由现金流IMVTTSHA
| Q4 25 | — | — | ||
| Q3 25 | — | $-24.3M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $-18.3M | ||
| Q3 24 | — | $-21.6M | ||
| Q2 24 | — | $-21.7M | ||
| Q1 24 | $-59.8M | $-19.9M |
自由现金流率IMVTTSHA
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -905.5% | ||
| Q3 24 | — | -1210.9% | ||
| Q2 24 | — | -1951.9% | ||
| Q1 24 | -714.4% | -584.5% |
资本支出强度IMVTTSHA
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | — | 2.0% | ||
| Q2 24 | — | 18.1% | ||
| Q1 24 | 1.8% | 4.1% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
